U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188251188251Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)CompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: gemcitabine/Eloxatin (GEMOX)|Drug: carboplatin/paclitaxel (CP)https://ClinicalTrials.gov/show/NCT00087802
188252188252CERE-110 in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseGenetic: CERE-110: Adeno-Associated Virus Delivery of NGFhttps://ClinicalTrials.gov/show/NCT00087789
188253188253Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant MelanomaCompletedNo Results AvailableMalignant MelanomaDrug: Chemotherapyhttps://ClinicalTrials.gov/show/NCT00087776
188254188254Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)CompletedNo Results AvailableMacular DegenerationDrug: Macugen â„¢ (pegaptanib sodium injection)https://ClinicalTrials.gov/show/NCT00087763
188255188255Interaction Between Cocaine and Quetiapine - 1Active, not recruitingNo Results AvailableCocaine-Related DisordersDrug: Quetiapinehttps://ClinicalTrials.gov/show/NCT00087750
188256188256Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDrug: DVS-233 SR|Drug: Venlafaxine ERhttps://ClinicalTrials.gov/show/NCT00087737
188257188257A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's DiseaseTerminatedNo Results AvailableAlzheimer's DiseaseDrug: FK962https://ClinicalTrials.gov/show/NCT00087724
188258188258A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerCompletedNo Results AvailableNon Small Cell Lung CarcinomaDrug: pemetrexed|Drug: gemcitabine|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00087711
188259188259Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural MesotheliomaCompletedHas ResultsPleural NeoplasmsDrug: pemetrexed|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00087698
188260188260RAD001 in Recurrent Endometrial Cancer PatientsCompletedNo Results AvailableEndometrial CancerDrug: RAD001https://ClinicalTrials.gov/show/NCT00087685
188261188261A Phase II Study of CC-5013 in MyelofibrosisCompletedHas ResultsMyelofibrosisDrug: CC-5013https://ClinicalTrials.gov/show/NCT00087672
188262188262A Prostate Cancer Study in Men Undergoing Androgen Deprivation TherapyCompletedNo Results AvailableProstate CancerDrug: zoledronic acidhttps://ClinicalTrials.gov/show/NCT00087659
188263188263REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination TherCompletedNo Results AvailableHepatitis C, ChronicDrug: Ribavirin|Drug: Ribavirin|Drug: peginterferon alfa-2a [Pegasys]|Drug: peginterferon alfa-2a [Pegasys]|Drug: peginterferon alfa-2a [Pegasys]|Drug: peginterferon alfa-2a [Pegasys]https://ClinicalTrials.gov/show/NCT00087646
188264188264PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.CompletedHas ResultsHepatitis C, ChronicDrug: peginterferon alfa-2a [Pegasys]|Drug: Copegushttps://ClinicalTrials.gov/show/NCT00087633
188265188265A Study of Capecitabine In Combination With Docetaxel Vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast CancerTerminatedNo Results AvailableBreast CancerDrug: XELODA [capecitabine]https://ClinicalTrials.gov/show/NCT00087620
188266188266PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).CompletedNo Results AvailableHepatitis C, ChronicDrug: Copegus|Drug: PEG-Intron|Drug: Rebetol|Drug: peginterferon alfa-2a [Pegasys]https://ClinicalTrials.gov/show/NCT00087607
188267188267A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.CompletedNo Results AvailableHepatitis C, ChronicDrug: peginterferon alfa-2a [Pegasys]|Drug: ribavirinhttps://ClinicalTrials.gov/show/NCT00087594
188268188268Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney TransplantationCompletedNo Results AvailableKidney TransplantationDrug: Cyclosporine or tacrolimus|Drug: Cyclosporine or tacrolimus|Drug: mycophenolate mofetil [CellCept]|Drug: mycophenolate mofetil [CellCept]https://ClinicalTrials.gov/show/NCT00087581
188269188269A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + RibavirinCompletedNo Results AvailableHepatitis C, ChronicDrug: Ribavirin|Drug: peginterferon alfa-2a [Pegasys]https://ClinicalTrials.gov/show/NCT00087568
188270188270Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of FibromyalgiaCompletedHas ResultsFibromyalgiaDrug: Xyrem (sodium oxybate) oral solution|Drug: Xyrem (sodium oxybate) oral solution|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00087555
188271188271Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational DrugCompletedNo Results AvailableHallucinations|Psychoses|Parkinson's DiseaseDrug: ACP-103https://ClinicalTrials.gov/show/NCT00087542
188272188272A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple SclerosisCompletedHas ResultsMultiple SclerosisDrug: placebo|Drug: rituximabhttps://ClinicalTrials.gov/show/NCT00087529
188273188273Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Sitagliptin (MK0431)|Drug: Sitagliptin|Drug: Placebo|Drug: Placebo|Drug: Metformin - Rescuehttps://ClinicalTrials.gov/show/NCT00087516
188274188274Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After ChemotherapyCompletedNo Results AvailableStomach NeoplasmsDrug: Edotecarinhttps://ClinicalTrials.gov/show/NCT00087503
188275188275Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedHas ResultsSkin/Soft Tissue Infections|Methicillin Resistant Staphylococcus Aureus (MRSA)Drug: linezolid|Drug: vancomycinhttps://ClinicalTrials.gov/show/NCT00087490
188276188276A Pilot Study of Pivanex in Patients With Malignant MelanomaTerminatedNo Results AvailableMalignant MelanomaDrug: Pivanexhttps://ClinicalTrials.gov/show/NCT00087477
188277188277Three Month Course of Anti-HIV Medications for People Recently Infected With HIVWithdrawnNo Results AvailableHIV InfectionsDrug: Emtricitabine|Drug: Nevirapine|Drug: Tenofovir disoproxil fumaratehttps://ClinicalTrials.gov/show/NCT00087464
188278188278Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)CompletedNo Results AvailableMalignant Glioma|Glioblastoma|GliosarcomaDrug: AP23573https://ClinicalTrials.gov/show/NCT00087451
188279188279Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung CancerCompletedHas ResultsLung CancerRadiation: stereotactic body radiation therapyhttps://ClinicalTrials.gov/show/NCT00087438
188280188280Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNo Results AvailableLeukemia|LymphomaBiological: rituximab|Drug: bryostatin 1https://ClinicalTrials.gov/show/NCT00087425

* Görseller ve İçerik tekif hakkına sahip olabilir